Supporting microglial niches for therapeutic benefit in psychiatric disorders

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Microglia are the primary immune cells in the central nervous system (CNS), regulating inflammation.
• Despite being immune privileged, the CNS allows microglia to communicate with the peripheral immune system.
• In a healthy CNS, microglia's typical inflammatory functions are largely suppressed, but they adopt immune mechanisms for homeostatic roles.

Purpose of the Study:

• To review preclinical evidence on microglia's conserved homeostatic niche functions.
• To explore how disruptions in these functions may cause psychiatric disorders.
• To identify potential therapeutic targets for restoring disrupted microglial niches.

Main Methods:

• Review of recent preclinical research on microglial functions in the CNS.
• Analysis of the role of sterile inflammation in neuroinflammation and psychiatric disorders.
• Identification of potential therapeutic strategies targeting microglial niches.

Main Results:

• Microglia engage in homeostatic functions using immune and inflammatory mechanisms without overt immune activation.
• Disruption of these specialized microglial functions is linked to the pathophysiology of psychiatric disorders.
• Preclinical evidence suggests conserved niche functions for microglia across various CNS contexts.

Conclusions:

• Microglia's role extends beyond traditional inflammatory responses to encompass critical homeostatic functions within the CNS.
• Understanding these sterile inflammatory functions opens avenues for novel therapeutic interventions for neuroinflammatory, neurodegenerative, and psychiatric conditions.
• Targeting disrupted microglial niches presents a promising strategy for treating psychiatric disorders.